Literature DB >> 14102016

METHYLDOPA IN TREATMENT OF SEVERE TOXAEMIA OF PREGNANCY.

S F HANS, H KOPELMAN.   

Abstract

Entities:  

Keywords:  ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; CHLOROTHIAZIDE; FETAL DEATH; METHYLDOPA; PHENOBARBITAL; PREGNANCY; PREGNANCY TOXEMIAS; PROGNOSIS; SEROTONIN INHIBITORS

Mesh：

Substances：

Year:  1964        PMID： 14102016      PMCID： PMC1815191          DOI： 10.1136/bmj.1.5385.736

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  POSSIBLE ROLE OF 5-HYDROXYTRYPTAMINE IN TOXAEMIA OF PREGNANCY.

Authors:  J B SENIOR; I FAHIM; F M SULLIVAN; J M ROBSON
Journal:  Lancet       Date:  1963-09-14       Impact factor: 79.321

2.  Drugs and rat pregnancy.

Authors:  G B WEST
Journal:  J Pharm Pharmacol       Date:  1962-12       Impact factor: 3.765

3.  Treatment of severe hypertension with methyldopa.

Authors:  M HAMILTON; H KOPELMAN
Journal:  Br Med J       Date:  1963-01-19

4.  Interruption of pregnancy before term: an evaluation of the mode of delivery and the factors which influence survival of the small infant.

Authors:  J A RIEDEL
Journal:  J Obstet Gynaecol Br Emp       Date:  1963-02

5.  Methyldopa in the treatment of hypertension.

Authors:  R I BAYLISS; E A HARVEY-SMITH
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

6.  Methyldopa in hypertension. Clinical and pharmacological studies.

Authors:  C T DOLLERY; M HARINGTON
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

7.  Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.

Authors:  L GILLESPIE; J A OATES; J R CROUT; A SJOERDSMA
Journal:  Circulation       Date:  1962-02       Impact factor: 29.690

8.  Diuretic effects of chlorothiazide in toxemia of pregnancy.

Authors:  N S ASSALI; L JUDD; N MONDZ; K DASGUPTA
Journal:  J Lab Clin Med       Date:  1958-09

9.  Experiences with mecamylamine in hypertensive complications of pregnancy.

Authors:  H AGAR; C T BARRETT; K A EXLEY
Journal:  J Obstet Gynaecol Br Emp       Date:  1958-06

10.  Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

Authors:  J A OATES; L GILLESPIE; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1960-06-24       Impact factor: 47.728
View more
  8 in total

1.  NEW LOOK AT TOXAEMIA OF PREGNANCY.

Authors:  H J LEHMANN
Journal:  Br Med J       Date:  1964-08-22

Review 2.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

3.  Some aspects of the long-term treatment of severe hypertension with methyldopa.

Authors:  M Hamilton
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

4.  Prolonged use of methyldopa in severe hypertension in pregnancy.

Authors:  P Kincaid-Smith; M Bullen; J Mills
Journal:  Br Med J       Date:  1966-01-29

5.  The role of amines in placental function. Monoamine metabolism in pregnancy.

Authors:  M Sandler
Journal:  Proc R Soc Med       Date:  1966-08

6.  New hypotensive drug.

Authors: 
Journal:  Br Med J       Date:  1966-09-24

7.  The long-term effectiveness of methyldopa in hypertension.

Authors:  R Okun; S E Roth; A Gordon; M H Maxwell
Journal:  Calif Med       Date:  1966-01

8.  A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy.

Authors:  H M Jones; A J Cummings; K D Setchell; A M Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.